Medical Device Translation Guide

Medical Device IFU Translation Guide: Workflow, Quality, and Version Control

Plan professional- and patient-use instructions for use with practical guidance on market requirements, terminology, translation review, multilingual publishing, electronic IFUs, revision control, and final-format quality assurance.

Specialist guide 14 practical chapters Includes a final IFU release checklist

Key Takeaways

Build Quality Into the Program Before Translation Begins

Accurate language is essential, but a dependable multilingual IFU also requires controlled scope, terminology, review, formatting, revision, and release decisions.

  • Confirm markets, languages, intended users, delivery formats, and approval responsibilities before translation begins.
  • Treat the approved source IFU as controlled product information, not as an isolated document.
  • Adapt language complexity to the intended user without changing approved safety or operating meaning.
  • Maintain terminology across IFUs, labels, packaging, device software, training, and support content.
  • Apply stronger review to safety-critical, operation-critical, and software-dependent content.
  • Inspect the final PDF, eIFU, or print-ready output—not only the translated text.

1. What Is a Medical Device IFU?

An instruction for use explains how a medical device should be used safely and as intended by the people who install, operate, maintain, prescribe, or use it.

Depending on the device and market, similar documents may be called directions for use, operating instructions, user manuals, operator manuals, patient guides, or accompanying information. The terminology varies, but the core responsibility is the same: the information must support safe, effective, and intended use.

An IFU may include:

  • Intended purpose, indications, contraindications, and intended users
  • Warnings, precautions, residual risks, and emergency actions
  • Device components, accessories, installation, setup, calibration, and preparation
  • Operating procedures, performance limitations, and troubleshooting
  • Cleaning, disinfection, sterilization, reprocessing, and maintenance
  • Storage, transportation, disposal, symbols, diagrams, and software references
  • Manufacturer, document, revision, and release information

ISO 20417:2026 provides a general framework for information supplied by medical-device manufacturers, including identification, labeling, packaging information, marking, and accompanying documentation such as IFUs.

IFUs, Labeling, and User Documentation Are Connected

An IFU belongs to a broader controlled information system that may include labels, packaging, quick-reference guides, device software, online help, training, service documentation, safety communications, and regulatory submissions. A term, warning, menu command, model name, or operating parameter that changes across these materials can create confusion even when each individual translation appears linguistically acceptable.

The goal is therefore not only to translate the IFU. It is to preserve consistent, traceable information across the complete device experience.

Explore Medical Device Translation Services

2. Why IFU Translation Requires a Controlled Process

IFU translation combines linguistic, technical, usability, regulatory, and publishing requirements. A workflow that addresses only words and sentences can overlook errors introduced through terminology, document structure, graphics, software references, or revision control.

A translated IFU may be linguistically accurate but still be unsuitable for release if:

  • A warning is separated from the procedure it governs.
  • A translated button name does not match the device interface.
  • A decimal, unit, operating range, or model identifier changes.
  • Text expansion hides part of a contraindication or operating step.
  • A translated layout carries an obsolete document revision.
  • A diagram contains untranslated or outdated labels.
  • The correct language is delivered for the wrong market or product configuration.

IFU Translation Control Model

Six Connected Controls for a Traceable Multilingual Release

Weakness in any one control can undermine the final IFU. Define the controls together before full translation begins.

Market Control

Where will the device be made available, and which language and delivery rules apply?

Output: Approved market-language matrix

Source Control

Which source document, product configuration, and revision are authorized for translation?

Output: Frozen or change-controlled source package

Language Control

Which terminology, audience, and style decisions must remain consistent?

Output: Approved terminology and language rules

Review Control

Who reviews each content type, and what evidence constitutes approval?

Output: Risk-based review and responsibility plan

Format Control

How will layout, graphics, software references, and final outputs be validated?

Output: Multilingual publishing and QA plan

Release Control

How will each language be linked to the correct device, market, revision, and approval?

Output: Traceable multilingual release record

3. Define Markets, Languages, Users, and Formats

The first major decision is not which translator to assign. It is what must be translated, for whom, for which markets, and in which delivery formats.

Create an approved translation brief before files are released. The brief should make product, market, language, user, format, review, and release assumptions visible to every participant.

Market and Language Planning Matrix

Planning Area Questions to Resolve
Target market In which countries or territories will the device be distributed?
Device scope Which device, model, accessory, configuration, or product family is covered?
Intended user Is the content for healthcare professionals, technicians, patients, caregivers, or mixed audiences?
Language Which official, regional, or customer-requested language variants are required?
Content scope Does the release include the IFU, quick guide, software help, labels, packaging, or training?
Delivery format Will the IFU be printed, electronic, embedded in software, online, or supplied in several formats?
Regulatory status Is the content for submission, approval, launch, corrective action, or a routine update?
Source revision Which approved source document and revision govern translation?
Review ownership Who approves terminology, language, technical accuracy, layout, and final release?
Release date Must all languages launch together, or will markets be released in phases?

Do Not Assume One Language List Applies Everywhere

For devices placed on the European Union market, manufacturers must determine the official language or languages required by each Member State. The European Commission maintains an overview of national language requirements, including certain requirements that affect graphical user interfaces.

For the United States, FDA device labeling is generally required in English, subject to specific provisions for U.S. territories and foreign-language representations. For other markets, confirm requirements through the manufacturer's regulatory and market-access process rather than through a generic global language list.

Plan Regional Language Variants Deliberately

A language name alone may not be sufficiently precise. European and Brazilian Portuguese, European and Canadian French, Simplified and Traditional Chinese, and market-specific Spanish or English variants may require separate terminology, adaptation, or approval. Document the decision rather than leaving it to individual translators or reviewers.

4. Prepare the Source IFU for Translation

Translation quality begins with source quality. Ambiguity, inconsistent terminology, unclear procedures, and uncontrolled revisions become more difficult to resolve after content has been distributed across multiple languages.

Approve or Control the Source

The source package should clearly identify:

Document Control

  • Final editable files and reference PDF
  • Source language, document number, and revision
  • Product, model, accessory, and configuration
  • Software or firmware version, when relevant
  • Effective or intended release date

Translation Control

  • Markets, languages, and delivery formats
  • Included and excluded content
  • Known pending changes
  • Previous approved translations and terminology
  • Reviewer and approver responsibilities

When translation must begin before the source is frozen, establish a formal change process. Record each source change, identify affected languages, and prevent informal edits from entering the release through email or reviewer comments without authorization.

Improve Source Translatability

  • Resolve long or syntactically ambiguous sentences and unclear pronoun references.
  • Define abbreviations and use one name for each device, component, and action.
  • Separate complex procedures into clear, ordered steps.
  • Associate warnings and precautions with the actions they govern.
  • Verify references to screens, buttons, figures, tables, and sections.
  • Identify noneditable graphics, hidden text, manual references, and unresolved comments.
  • Control units, dates, decimal conventions, model numbers, and technical values.

Write for the Intended User

The same device information may need a different presentation for a surgeon, clinical technician, home user, or caregiver. The EU MDR requires the medium, format, content, legibility, and location of information to be appropriate to the device, its intended purpose, and the knowledge, education, and training of the intended user. FDA patient-labeling guidance similarly emphasizes clear, logically organized language for lay readers.

Professional-Use and Patient-Use IFU Considerations

Consideration Professional-Use IFU Patient- or Lay-User IFU
Expected knowledge May assume clinical, scientific, engineering, or technical training. Should minimize assumed technical knowledge and explain unavoidable specialist terms.
Instruction style Can include complex setup, reprocessing, maintenance, and institutional procedures. Should use direct, action-oriented steps with clear sequencing and decision points.
Terminology May use recognized professional terminology when it matches the intended user. Should prioritize comprehension while preserving approved clinical and safety meaning.
Software interaction May reference advanced controls, settings, and institutional workflows. Should make controls, feedback, error conditions, and requests for professional help easy to recognize.
Validation focus Technical and operational accuracy, specification alignment, and workflow fit. Comprehension, usability, accessibility, and safe action by the intended user.

5. Build and Govern Medical Device Terminology

Terminology decisions should be made before they appear in dozens of translated pages, screens, labels, graphics, and review comments.

A medical-device termbase should capture product, clinical, technical, software, safety, and market-specific language that requires controlled use. Each entry needs enough context to guide the translator and reviewer; an isolated source and target word pair is often insufficient.

Recommended Termbase Fields

  • Source term and definition
  • Approved target term
  • Part of speech and usage context
  • Product or content applicability
  • Example sentence
  • Allowed abbreviation
  • Prohibited alternatives
  • Applicable market or language variant
  • Approval status and approver
  • Revision history

Establish Terminology Ownership

Regulatory, quality, engineering, clinical, product, and localization teams may all contribute, but one controlled process should govern final approval. Assign responsibility for candidate-term extraction, source definitions, translation proposals, ambiguity resolution, local variants, deprecated terms, and change communication.

Coordinate Terms Across the Device Experience

The approved term for a component, operating mode, warning, or user-interface command should normally remain consistent across IFUs, labels, packaging, software, quick guides, training, service documentation, support content, and safety communications. A change in one channel should trigger an impact assessment across the others.

Manage Symbols as Controlled Information

Symbols can reduce space and support international consistency, but they still require document control. Confirm that the correct symbol version is used, that accompanying explanations remain accurate, and that proprietary or unfamiliar symbols are explained where required. ISO 15223-1 defines symbols used with information supplied for medical devices, including symbols appearing on the device, packaging, and accompanying information.

6. Design the Translation and Review Workflow

A controlled workflow defines inputs, responsibilities, review gates, exceptions, and release evidence before the first target language is produced.

Ten Stages From Controlled Source to Approved Release

  1. Scope and File Analysis

    Confirm markets, languages, source revision, editable files, word volume, repetitions, graphics, software references, and publishing requirements.

  2. Source-Content Review

    Resolve ambiguity, comments, inconsistent terminology, missing references, and known source defects before they multiply across languages.

  3. Terminology Preparation

    Extract and approve product, clinical, technical, software, safety, and regulatory terms that require controlled use.

  4. Translation Memory Preparation

    Validate prior translations, remove obsolete assets, and align suitable historical content for controlled reuse.

  5. Professional Translation

    Assign target-language linguists with the required medical-device, technical, and intended-user expertise.

  6. Independent Linguistic Review

    Review meaning, completeness, terminology, grammar, clarity, numerical content, and alignment with the approved source.

  7. Technical or In-Country Review

    Route content for additional review when device complexity, risk, market practice, or the manufacturer’s quality process requires it.

  8. Multilingual Publishing

    Format translated content in the required authoring system while preserving warning hierarchy, figures, tables, references, and document metadata.

  9. Final-Format QA

    Inspect the actual PDF, electronic output, or print-ready file for linguistic, visual, technical, and release defects.

  10. Approval and Controlled Release

    Record source and target revisions, approvals, deliverables, effective dates, archive locations, and release status.

Assign Clear Roles and Decision Rights

Typical IFU Translation Responsibilities

Role Typical Responsibilities
Regulatory affairs Confirms market requirements, languages, regulatory scope, and approval needs.
Quality assurance Defines controlled-document, supplier, approval, traceability, and release requirements.
Technical writing Maintains the source IFU and resolves source-content questions.
Engineering or product Confirms device behavior, specifications, components, and software references.
Clinical or medical reviewer Reviews clinical meaning and intended-user terminology when required.
Localization manager Coordinates scope, files, language assets, reviewers, schedule, and delivery.
Translator Produces accurate target-language content using approved references and terminology.
Independent reviewer Checks the translation against the source and the defined quality requirements.
In-country reviewer Confirms approved local terminology or market usage within a defined remit.
Publishing specialist Produces and corrects the final multilingual layout.
Final approver Authorizes the language version for release under the manufacturer’s quality process.

Define the In-Country Reviewer's Remit

Unstructured in-country review often creates delays and inconsistent edits. Give reviewers the approved source, target translation, terminology, audience guidance, review criteria, comment categories, deadline, escalation method, and clear decision rights. A preference change should not automatically override approved terminology or introduce meaning that is not present in the source.

Route Review According to Risk

Not every sentence requires the same level of review. A risk-based model concentrates expert attention where an error could have the greatest effect while retaining a controlled professional workflow for lower-risk content.

IFU Content Risk-Routing Matrix

Content Category Examples Recommended Review Route
Safety-Critical Contraindications, warnings, precautions, residual risks, emergency actions Specialist translation, independent review, terminology validation, required subject-matter expert or regulatory review, and final-format QA
Operation-Critical Setup, calibration, parameter settings, procedures, reprocessing, maintenance Specialist translation, independent review, technical validation where needed, and final-format QA
User-Interface Dependent Buttons, menus, alerts, screen paths, error messages, embedded help Translation with approved UI terminology, software cross-check, and linguistic or functional testing
Explanatory Product descriptions, background information, general explanations Professional translation and review appropriate to the intended audience and content risk
Administrative Contact information, copyright, generic headings, nontechnical boilerplate Standard professional workflow with automated checks and final verification

Use Back Translation for a Defined Purpose

Back translation can help examine meaning after translation without requiring the reviewer to know the target language. It should not be treated as a universal substitute for qualified forward translation, independent bilingual review, terminology control, technical validation, usability work, or final-format QA.

Explore Translation Quality Assurance

7. Use AI Responsibly in IFU Translation

AI can accelerate parts of the process, but it does not remove the need for controlled language assets, medical-device expertise, human judgment, and documented quality assurance.

Where AI and Automation Can Help

  • Source analysis and terminology extraction
  • Detection of repeated or similar content
  • Initial translation of eligible segments
  • Revision comparison and change classification
  • Terminology, numerical, and completeness checks
  • Quality signals and reviewer routing

Where Stronger Human Control Is Needed

  • Warnings, precautions, and contraindications
  • Patient- and lay-user instructions
  • Critical operating and emergency procedures
  • Reprocessing, calibration, and measurement content
  • Device-software interactions and safety-related updates
  • Novel, ambiguous, or highly specialized terminology

Translation Memory Is Not the Same as Generative AI

Translation memory stores previously translated source and target segments for controlled reuse. Generative AI or machine translation produces new target-language output. A mature workflow may use both: approved translation memory for reuse, terminology management for controlled vocabulary, AI for eligible new content, automated QA for detectable defects, and qualified professionals for validation and release decisions.

8. Manage Multilingual Layout and Publishing

Translation changes the physical behavior of a document. Words expand or contract, line breaks move, tables grow, page references shift, and some fonts fail to support required scripts.

These changes matter because layout helps users understand sequence, hierarchy, warnings, and the relationship between text and visuals. Multilingual publishing should therefore be planned as part of the IFU workflow rather than treated as a final cosmetic step.

Common Multilingual Publishing Challenges

  • Text expansion and heading fit
  • Warning-box overflow
  • Table and callout breaks
  • Incorrect list or step numbering
  • Broken cross-references
  • Unsupported fonts or characters
  • Untranslated graphics
  • Right-to-left layout errors
  • Page-count changes
  • Incorrect headers, footers, or revision identifiers
  • Low-resolution images after export
  • Broken links, bookmarks, or accessibility navigation

Plan Right-to-Left Languages as a Layout Requirement

Arabic, Hebrew, and other right-to-left languages require more than right-aligning paragraphs. Review reading direction, number and unit placement, ordered procedures, tables, icons, arrows, diagrams, mixed-language product names, software screenshots, navigation, headers, and footers. Some visual elements should be mirrored; others must retain their original orientation because of their technical meaning.

Control Text Inside Graphics

Inventory all graphics containing translatable text before project launch. Decide whether each graphic will be edited, recreated, converted to numbered callouts with a translated legend, replaced with a language-neutral illustration, retained in the source language, or recaptured from localized software.

Validate the Exported Output

Inspect the final PDF or electronic file independently from the editable source. Exporting can introduce missing fonts, changed line breaks, clipped content, low-resolution images, broken bookmarks, transparency problems, printer marks, or accessibility defects.

Explore Multilingual Desktop Publishing

9. Control Revisions and Electronic IFUs

Multilingual version control should connect every released language to the correct source content, product configuration, market, software version, approval, and distribution channel.

Minimum Version-Control Information

  • Product or device family
  • Model or configuration
  • Source document number and revision
  • Target-language document number and revision
  • Language and regional variant
  • Applicable market
  • Software or firmware version, when relevant
  • Translation and review status
  • Approval and effective dates
  • Released file name and archive location
  • Superseded version

Use Change-Impact Analysis

  1. Identify changed, added, moved, and deleted content.
  2. Determine whether the change affects meaning, terminology, layout, graphics, software references, or safety.
  3. Identify every affected language, market, product, and delivery channel.
  4. Retrieve valid prior translations and route changed content for contextual review.
  5. Check unchanged text affected by headings, pagination, figures, or surrounding procedures.
  6. Regenerate and inspect final outputs, update revision histories, and record approvals.
  7. Withdraw, archive, or clearly identify superseded files before the new release becomes effective.

An unchanged sentence may still require review when its heading, warning context, numbered step, figure reference, or surrounding procedure changes.

Use Controlled File Names

Electronic IFUs Add Operational Requirements

Electronic delivery can improve access, distribution, and update management, but it also requires documented risk assessment, reliable access, revision communication, protection against tampering, backup arrangements, paper-copy processes where required, and controlled availability of current and prior versions.

The consolidated EU eIFU rules permit electronic rather than paper IFUs for qualifying professional-use devices and medical-device software under defined conditions. Where it is reasonably foreseeable that a professional-use device will also be used by lay persons, instructions intended for those lay users must be supplied in paper form.

For devices covered by these rules, the paper-copy process must provide requested instructions at no additional cost and, at the latest, within seven calendar days. Manufacturers must also manage revision identification, website availability, and access to issued and obsolete versions for the applicable retention period.

10. Perform Final-Format Quality Assurance

Text review and final-format QA serve different purposes. A translation can be linguistically approved before formatting and still contain omissions, truncation, broken references, or incorrect release information in the final file.

Gate 1: Linguistic QA

  • Accuracy, completeness, and approved terminology
  • Warnings, precautions, contraindications, and procedural meaning
  • Device names, numbers, units, ranges, and references
  • Language appropriate to the intended user

Gate 2: Visual and Functional QA

  • Clipping, overflow, fonts, headings, lists, tables, and callouts
  • Graphics, captions, page references, links, bookmarks, and QR codes
  • Right-to-left display, print size, screen behavior, and accessibility
  • Association of safety information with the relevant action

Practical Tool

Final IFU Release Checklist

Use this checklist immediately before approving a translated IFU for distribution.

Scope

  • Product, model, accessory, and configuration confirmed
  • Target market confirmed
  • Language and regional variant confirmed
  • Intended user confirmed
  • Delivery format confirmed

Source and Change Control

  • Approved source revision confirmed
  • All source changes captured
  • Translation memory validated
  • Previous approved translations assessed
  • Obsolete content excluded

Language Quality

  • Translation and independent review complete
  • Approved terminology applied
  • Safety information verified
  • Numbers, units, and references verified
  • Software terminology cross-checked
  • Reviewer comments resolved

Publishing

  • Layout and text expansion corrected
  • Graphics localized
  • Fonts and character rendering verified
  • Tables, callouts, and cross-references checked
  • Headers, footers, and revision data checked
  • Final PDF or electronic output inspected

Release

  • Correct document and language identifiers applied
  • Required approvals recorded
  • Final file name confirmed
  • Links and QR codes tested
  • Superseded version controlled
  • Approved deliverable archived and distributed

11. Avoid Common IFU Translation Failures

Many multilingual defects originate in planning, review, layout, or release control rather than in sentence-level translation. Use the failure patterns below as a prelaunch diagnostic.

Translating Before the Source Is Stable

Risk: Multiple rounds of retranslation, inconsistent updates, and uncertainty about which content is approved.

Prevention: Freeze the source or use a documented change process with version comparison and impact analysis.

Assuming Every Market Uses the Same Language Rules

Risk: Missing languages, unnecessary translation, or an inappropriate regional variant.

Prevention: Maintain a market-language matrix approved by regulatory affairs.

Treating the IFU as an Independent Document

Risk: Terminology conflicts with labels, packaging, software, quick guides, and training.

Prevention: Govern terminology and revisions across the complete device information system.

Using Translators Without Device Context

Risk: Clinically plausible wording may misrepresent a component, procedure, control, or technical function.

Prevention: Match linguists to the device subject, document type, intended user, and technical complexity.

Allowing Unstructured Reviewer Rewriting

Risk: Subjective changes create inconsistency and can introduce meaning that is not present in the source.

Prevention: Provide review criteria, approved terminology, comment categories, and clear decision rights.

Reusing Translation Memory Without Context Review

Risk: A previously valid translation may be wrong for a different model, warning level, user, or software function.

Prevention: Validate matches in context and route higher-risk reused content for stronger review.

Reviewing Text but Not the Final Output

Risk: Overflow, omitted content, broken references, and release-data errors remain undetected.

Prevention: Perform independent final-format linguistic, visual, and release QA.

Using AI Without Risk-Based Human Review

Risk: Fluent output can still alter warnings, omit qualifications, or introduce unsupported terminology.

Prevention: Govern AI by content risk, protect approved terminology, and require qualified human validation.

12. Evaluate an IFU Translation Provider

Evaluate the provider's ability to support the complete controlled workflow—not only its word rate or the number of languages it offers.

Medical Device Expertise

  • Relevant device-category and document experience
  • Clear qualification criteria for translators and reviewers
  • Ability to distinguish professional, patient, software, and technical audiences
  • Support for clinical, engineering, regulatory, and publishing content

Quality Management

  • Documented controls for files, language assets, reviews, approvals, and deliverables
  • Traceability for revisions, queries, reviewer decisions, and corrective actions
  • Supplier controls appropriate to the manufacturer’s quality system
  • Practical workflows that complement—not merely reference—quality certifications

Terminology and Translation Memory

  • Creation and maintenance of approved multilingual terminology
  • Ownership and portability of language assets
  • Enforcement of prohibited terms and product-specific variants
  • Validation and segmentation of historical translations

Multilingual Publishing

  • Support for the required authoring and graphics applications
  • Right-to-left and complex-script publishing capability
  • Final-format linguistic QA by qualified target-language reviewers
  • Reliable management of graphics, cross-references, tables, and metadata

Technology, AI, and Security

  • Transparent explanation of where AI is used and where it is excluded
  • Integrated terminology, translation memory, automated QA, and human review
  • Appropriate controls for confidential information, access, retention, and traceability
  • Scalable workflows for simultaneous launches and ongoing updates
Explore Professional IFU Translation Services

13. Plan and Launch the Program

A representative pilot can validate terminology, reviewer responsibilities, publishing, and release controls before the workflow expands across a full device portfolio.

Before Kickoff

  • Confirm markets, languages, product, source revision, users, and delivery formats.
  • Inventory editable files, graphics, software references, and prior translations.
  • Identify terminology owners, reviewers, approvers, and decision rights.
  • Establish security, access, file naming, change control, and release requirements.

During the Pilot

  • Select representative safety, operating, software, table, graphic, and layout content.
  • Evaluate translation quality, terminology, questions, review efficiency, and DTP.
  • Test final-format QA, revision traceability, delivery reporting, and approval evidence.
  • Resolve the pilot findings before scaling to additional languages and products.

Before Scaling

  • Approve the terminology and validate translation memory.
  • Document reviewer instructions and the content risk-routing matrix.
  • Confirm templates, release records, archival processes, and quality metrics.
  • Define how urgent safety-related updates will be routed and synchronized.
  • Schedule periodic terminology, workflow, supplier, and performance reviews.

Measure the Program, Not Only the Project

Useful indicators include terminology compliance, first-pass acceptance, reviewer change categories, reopened defects, final-format defect rates, reuse of approved content, source questions, safety-update turnaround, revision alignment across languages, and approval timeliness. Use the data to improve the source, terminology, workflow, technology, publishing, and governance model.

14. Frequently Asked Questions

These answers address common planning questions from regulatory, quality, technical documentation, localization, and product teams.

Medical device IFU translation is the controlled process of converting instructions for use into one or more target languages while preserving approved technical, clinical, operational, and safety meaning. The process may include terminology management, independent review, multilingual publishing, final-format QA, and revision control.

Primary Standards and Regulatory Resources

Regulatory and standards information changes over time. Confirm the current edition, consolidated text, national requirements, and device-specific applicability before making release decisions.

  • ISO 20417:2026 — Medical Devices — Information to Be Supplied by the Manufacturer

    International Organization for Standardization

    View ISO 20417
  • Regulation (EU) 2017/745 on Medical Devices

    EUR-Lex

    View EU MDR
  • Overview of Language Requirements for Manufacturers of Medical Devices

    European Commission

    View Language Requirements
  • General Device Labeling Requirements

    U.S. Food and Drug Administration

    View FDA Labeling Requirements
  • Guidance on Medical Device Patient Labeling

    U.S. Food and Drug Administration

    View FDA Patient Labeling Guidance
  • ISO 15223-1:2021 — Symbols to Be Used With Information Supplied by the Manufacturer

    International Organization for Standardization

    View ISO 15223-1
  • Commission Implementing Regulation (EU) 2021/2226 on Electronic IFUs, Consolidated 2025

    EUR-Lex

    View Consolidated eIFU Rules
  • ISO 13485:2016 — Medical Devices — Quality Management Systems

    International Organization for Standardization

    View ISO 13485

Practical Next Step

Connect Language Quality With Document and Release Control

A dependable IFU translation program aligns market requirements, intended-user comprehension, approved terminology, risk-based review, device-software consistency, multilingual publishing, revision control, and final release assurance. Start with a representative source package and use the framework in this guide to define responsibilities before the first multilingual release.

Build a More Controlled Multilingual IFU Workflow

Stepes helps medical device companies translate and manage IFUs, labeling, device software, technical documentation, and related content across global markets with professional linguists, terminology management, translation memory, AI-assisted automation, independent review, multilingual publishing, and final-format QA.